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The prostate gland consists of basal and luminal cells
arranged as pseudostratified epithelium. In tissue
recombination models, only basal cells reconstitute
a complete prostate gland, yet murine lineage-
tracing experiments show that luminal cells generate
basal cells. It has remained challenging to address
themolecular details of these transitions andwhether
they apply to humans, due to the lack of culture con-
ditions that recapitulate prostate gland architecture.
Here, we describe a 3D culture system that supports
long-term expansion of primary mouse and human
prostate organoids, composed of fully differentiated
CK5+ basal and CK8+ luminal cells. Organoids are
genetically stable, reconstitute prostate glands in
recombination assays, and can be experimentally
manipulated. Single human luminal and basal cells
give rise to organoids, yet luminal-cell-derived orga-
noids more closely resemble prostate glands. These
data support a luminal multilineage progenitor cell
model for prostate tissue and establish a robust,
scalable system for mechanistic studies.
INTRODUCTION
The prostate is a male sex gland responsible for approximately
30% of all seminal fluid. Although prostate glands differ between
species, macroscopically prostatic acini are organized similarly
at the cellular level. Prostatic ducts are lined by a pseudostrati-
fied epithelium. Three major cell types are identified within the
epithelium: (1) secretory luminal cells marked by cytokeratin
(CK) 8, CK18, androgen receptor (AR) and secretory proteins
like prostate-specific antigen (PSA); (2) basal cells, identified
by the expression of CK5, CK14, and p63; and (3) rare neuroen-
docrine cells (Shen and Abate-Shen, 2010). In the developing
and adult prostate, rare, intermediate cells expressing both
luminal and basal markers are present (Hudson et al., 2001;
Xue et al., 1998).The identity of prostatic stem cells and how they give rise to
these three cell types remains unclear. The classic urogenital si-
nus mesenchyme (UGSM) recombination model, where prostate
epithelial cells are combined with mesenchymal cells derived
from the urogenital sinus (UGS) ofmurine embryos and are trans-
planted under the kidney capsule (Cunha, 1973; Xin et al., 2003),
suggests that only basal cells are capable of generating glan-
dular tissue (Goldstein et al., 2008). Other approaches to identify
prostate stem cells involve in vitro culture methods of primary
prostate epithelium (Garraway et al., 2010; Liu et al., 2012; Niran-
jan et al., 2013). In these approaches, basal cells appear bipo-
tent, i.e., capable of generating both luminal and basal lineages,
indicating that basal cells have stem-like potential. However,
none of these in vitro systems generate tissues that resemble
the in vivo composition of the prostate gland or contain AR at
physiological levels.
Recently, novel insights have been generated into the cellular
hierarchy of the prostatic epithelium in mice through lineage
tracing. Studies marking Ck5-expressing (Ck5+) basal cells
and Ck8+ luminal cells suggest that basal and luminal lineages
both harbor stem cell activity in the adult prostate (Choi et al.,
2012; Ousset et al., 2012). However, in a separate study, rare
multipotent basal cells reside in the adult prostate (Wang et al.,
2013). While lineage tracing from Ck8+ and Ck18+ cells sug-
gests unipotency in the luminal lineage (Choi et al., 2012; Ousset
et al., 2012), a subset of luminal cells defined by Nkx3.1 expres-
sion postcastration can generate both lineages during regenera-
tion of the prostate (Wang et al., 2009). Taken together, these
studies suggest that in mice both luminal and basal cells sporad-
ically are bipotent.
Although these studies provide important insights into pros-
tate biology, translating these results to a human setting is diffi-
cult. One challenge is the expression pattern of the proposed
stem cell markers c-kit, CD177, and CD133, which are exclu-
sively expressed by basal cells in humans, but in mice are ex-
pressed by basal cells and a subset of luminal cells (Leong
et al., 2008; Missol-Kolka et al., 2011). Translation to a human
setting is also hampered by the lack of suitable human experi-
mental systems.
We have previously described 3D culture conditions that allow
long-term expansion of primary mouse and human epithelialCell 159, 163–175, September 25, 2014 ª2014 Elsevier Inc. 163
organoids from small intestine (Sato et al., 2009), colon (Sato
et al., 2011), stomach (Barker et al., 2010), and liver (Huch
et al., 2013). These cultures can be initiated from single Lgr5+
stem cells and are based on the addition of the Lgr4/5 ligand
R-spondin1, a potent Wnt pathway agonist (Binnerts et al.,
2007; Carmon et al., 2011; de Lau et al., 2011). Organoids remain
genetically and phenotypically stable in culture, exemplified by
pathology-free transplantation ofmultiplemicewith the organoid
offspring of single Lgr5+ cells from colon (Yui et al., 2012) or liver
(Huch et al., 2013).
Here, we describe the development of an R-spondin1-based
culture method that allows long-term propagation of murine
and human prostate epithelium. Using this method, we show
that both basal and luminal populations contain bipotent progen-
itor cells, which retain full differentiation toward basal and luminal
lineages in vitro and in the UGSM transplantation model. More-
over, we show that organoid cultures can be used to study pros-
tate cancer initiation.
RESULTS
Establishment of Primary Murine Prostate Organoid
Cultures with Basal and Luminal Epithelial Layers
To establish murine prostate organoid cultures, we embedded
dissociated cells of wild-type murine prostate epithelium in
Matrigel and added ‘‘generic’’ organoid medium containing
the growth factors EGF, Noggin, and R-spondin1 (ENR) (Sato
et al., 2009). We also included the Alk3/4/5 inhibitor A83-01 to
inhibit TGF-b pathway signaling to prevent a proliferative block
in prostate cells (Ding et al., 2011; Qin et al., 2013). Because
the murine prostate is composed of different lobes with some
distinct properties (Marker et al., 2003), we separately cultured
the anterior prostate (AP), dorsolateral prostate (DLP), and
ventral prostate (VP) epithelium (Figure S1A, available online).
Prostate cells from each lobe yielded expanding organoids.
These have been cultured at a split ratio of 1:3 for >1.5 years
with stable, normal karyotypes (Figure S1B) and no changes in
morphology.
Prostate epithelium formed cystic structures composed of a
basal (outer) layer exclusively expressing typical basal prostate
markers, such as p63 and Ck5, and a luminal (inner) layer exclu-
sively expressing Ck8 (Figures 1A and 1B and S1D), thus demon-
strating that organoids retain an architecture that resembles
prostate glands in vivo, with the exception that we did not detect
neuroendocrine cells.
Organoids also retained robust expression of the Ar (Figure 1A)
and theprostate-specific transcription factorNkx3.1 (FigureS1C)
(Bhatia-Gaur et al., 1999). Ar signaling was intact, as demon-
strated by nuclear translocation of Ar in organoids treated with
dihydrotestosterone (DHT). Within 72 hr after DHT addition,
Ck8+ luminal cells became strongly polarized with an apparent
increase in size (Figure 1A). Moreover, we found occasional dou-
ble p63+ and Ar+ cells (Figure 1B), consistent with the differen-
tiation-promoting function of Ar in normal prostate cells (Litvinov
et al., 2006). Two classic Ar target genes, Fkbp5 and Psca, were
robustly upregulated (Figure 1D). DHT also enhanced the rate at
which organoids expanded, allowing weekly split ratios of 1:5
rather than 1:3. Organoids also retained DHT responsiveness164 Cell 159, 163–175, September 25, 2014 ª2014 Elsevier Inc.aftermultiple cycles ofDHTaddition andwithdrawal (Figure S1E),
consistent with the response of the normal prostate gland to
castration and DHT add-back in vivo.
As has been shown for primary murine prostate tissue, pros-
tate organoids gave rise to reconstituted prostate glands when
placed under the kidney capsule with urogenital mesenchymal
cells (Figure 1C, Figure S1J), using a tissue recombination assay
(Xin et al., 2003). Importantly, this reconstitution property was re-
tained after eight passages with organoids derived from the AP,
DLP, or VP, indicating long-term retention of prostate progenitor
cells. In the grafts, we did not observe morphologies reminiscent
of the respective lobes of the prostate, suggesting that this is im-
parted by local, nonepithelial cues in the prostate as has been
shown by others (Hayashi et al., 1993; Timms et al., 1995).
We examined the relative requirement of each ingredient by
quantifying the number of organoids formed after seeding
1,000 single cells and tracking successive passages. Noggin
increased the number of organoids formed during initial plating
(Figure S1G) and resulted in faster expansion rates but was not
absolutely required for serial passaging (Figure S1H). This is in
line with observations in the development of the prostate in
Noggin knockout mice, where reduced epithelial proliferation
and reduced prostate budding is observed due to hyperactive
bone morphogenetic protein (BMP) signaling (Cook et al.,
2007). Similarly, the Wnt agonist R-spondin enhanced organoid
formation and expansion, but was not absolutely required for
expansion. R-spondins and Wnts are widely expressed in the
urogenital sinus during prostate development (Mehta et al.,
2011), and Wnt signaling is essential for prostate development
(Francis et al., 2013). Moreover, the R-spondin receptor Lgr4 is
essential for both prostate development as well as differentiation
(Luo et al., 2013). We found that organoids express Lgr4 and
Lgr5 (Figure S1I). DHT was not essential but significantly
enhanced the efficiency of organoid formation (Figures S1G
and S1H). EGF was essential for both establishment and
passaging. TGF-b pathway inhibition was required for passaging
of AP- and VP-derived organoids, but not for DLP-derived orga-
noids (Figures S1F–S1H).
Both Luminal and Basal Cells Can Generate Murine
Prostate Organoids
The availability of a robust in vitro murine prostate organoid
system with basal and luminal layers allowed us to determine
whether isolated basal or luminal cells are capable of estab-
lishing organoids. We separated basal and luminal cells from
primary mouse prostate tissue using FACS. Basal cells were iso-
lated based on high CD49f expression (also called a6-integrin)
(Goldstein et al., 2008), luminal cells were captured based on
expression of CD24 (also called heat stable antigen [HAS]; Fig-
ure 2A). CD24 was previously shown to specifically mark luminal
cells in the human prostate (Liu et al., 2004), and CD24 expres-
sion has been used in conjunction with CD49f to isolate murine
luminal cells (Lawson et al., 2007). We confirmed luminal-spe-
cific high CD24 expression in murine prostate tissue by IHC (Fig-
ure S2A). The purity of our sorted basal and luminal population
was verified using qPCR for basal- and luminal-specific markers,
Ck5 and Probasin (Pbsn) (Figure 2B), and costaining for luminal-
cell-specific Ck8 and basal-cell-specific Ck5 (Figure S2B).
Figure 1. Establishment of Murine Prostate Cultures
(A) IHC analysis of murine organoids in the presence of DHT (1 nM) and in castrate conditions. Brightfield image (I and II) H&E staining (III and IV) Ck8 (V and VI) p63
(VII and VIII) Ar (IX and X). Strong increase in cell size is observed upon DHT addition as well as nuclear localization of the Ar. Scale bars, 50 mm.
(B) IF staining (I) of basal Ck5 (green) and luminal Ck8 (red) in organoids. Distinct luminal and basal cell populations are present in organoids. Bottom (II) staining for
p63 (green) and Ar (red) showing single positive (green and red arrowhead) and double-positive Ar/p63 cells (yellow arrowhead).
(C) H&E stain of UGSM recombination 8 weeks after transplantation of 50,000 organoid cells derived from wild-type mice. Inset; Ck5 staining, confirming
presence of basal cells.
(D) Quantitative RT-PCR of Ar targets Psca and Fkbp5 in the presence of DHT (1 nM) and in castrate conditions (24 hr). Psca and Fkbp5 transcripts are increased
upon DHT addition. Expression was normalized to Hprt. Results are shown as mean ± SD.
See also Figure S1We found a contamination of 0.04% of Ck5+ basal cells (2
cells in 5,000 cells, determined in two independent samples) in
the CD24+ fraction.
To measure their organoid-forming capability, we seeded 200
single basal- or luminal-derived cells in culture, i.e., one cell per
Matrigel drop. Approximately 15%of basal cells formed an orga-
noid, compared to 1% of luminal cells (Figure 2C). Yet, the
growth of luminal cells could not be explained by the presence
of contaminating basal cells. Considering 15% of basal cells
grow out, a basal cell contamination of >6% is required to
explain an outgrowth efficiency of 1% of luminal cells, whereas
we only found 0.04% of contaminating basal cells. Finally,CD24/CD49f double-negative cells, which represent nonepithe-
lial cells, did not grow (Figure 2C).
Despite the difference in cloning efficiency, we did not observe
morphological differences in organoid development from single
cells. Both luminal and basal cells initially formed a solid
ball and subsequently developed into a sphere within 10 to
14 days (Figure S2C). IHC analysis showed that the organoids
derived from either basal or luminal cells expressed both basal
(p63, Ck5) and luminal (Ck8) markers and express Ar (Figure 2D).
Furthermore, both luminal- and basal-derived murine organoids
could be passaged long-term. These data are consistent with
recent lineage-tracing studies (Choi et al., 2012; Wang et al.,Cell 159, 163–175, September 25, 2014 ª2014 Elsevier Inc. 165
Figure 2. Basal and Luminal Cells Give Rise to Organoids
(A) FACS plot of CD24 (luminal) CD49f (basal) stained murine prostate.
(B) Quantitative RT-PCR expression analysis of basal (Ck5) and luminal (Probasin, Pbsn) marker expression in CD24+ luminal and CD49f+ basal cells. Pbsn is
strongly expressed in luminal cells; Ck5 is strongly expressed in basal cells. Expression was normalized to Hprt. Results are shown as mean ± SD.
(C) Percentage of organoids established by 200 single cells 14 days postseeding. Approximately 15% of basal cells generate an organoid. 1% of luminal cells
generate an organoid. Results are shown as mean ± SD.
(D) IHC stainings of single-cell-derivedmurine prostate organoids, showing similar staining patterns of Ar (I and II), Ck8 (III and IV), Ck5 (V–VI) and p63 (VII and VIII)
and morphology, showing that basal cells and luminal cells are both capable of giving rise to both epithelial lineages. Scale bars, 50 mm.
See also Figure S22009; Wang et al., 2013) and support the existence of prostate
stem cells in both the basal and luminal compartments of the
normal mouse prostate.
Murine Prostate Organoids as a Tool for Cancer Biology
To explore the suitability of prostate organoid cultures for ge-
netic studies, we asked if we could generate cancer phenotypes
using known prostate cancer oncogenes or tumor suppressor166 Cell 159, 163–175, September 25, 2014 ª2014 Elsevier Inc.genes that have been previously characterized in genetically en-
gineered mouse models (GEMMs). We established organoids
from mice with a floxed Pten allele (PtenloxP/loxP) (Di Cristofano
et al., 1998), a TMPRSS2:ERG gene fusion (Rosa26 LSL-ERG)
(Chen et al., 2013) or bigenic Pten/Rosa26LSL-ERG mice and
compared their phenotypes to organoids derived from wild-
type mice. In these experiments, Cre-driven excision of
loxP-flanked regions was mediated by the prostate-specific
composite promoter ARR2PB (PBCre) (Figure S3A). Cultures
carrying the prostate-specific Pten deletion initially formed
normal-appearing organoids containing a lumen, but within a
week the organoids had multiple layers of epithelium, eventually
forming a nearly solid 3D structure (Figure 3A). Histologically,
PBCre PtenloxP/loxP organoid resembled phenotypes observed
in vivo (Carver et al., 2011), with features reminiscent of high-
grade PIN. Organoids derived from PBCre Rosa26 LSL-ERG
mice showed no signs of neoplasia (Figures 3A andS3B), consis-
tent with the in vivo phenotype (Carver et al., 2009; Chen et al.,
2013). The combination of Pten deletion and ERG overexpres-
sion yielded a hyperplastic phenotype similar to that seen with
Pten deletion alone (Figures 3A and S3B), but with ‘‘fingers’’ pro-
truding into the Matrigel (Figure 3A), suggesting invasive
behavior. All organoids responded to DHT withdrawal with
reduced Fkbp5 expression (Figure S3C). Furthermore, the histo-
logic features attributable to Pten and ERG in vitro were
confirmed in UGSM tissue recombination experiments of trans-
planted passage-8 organoids (Figure S3B).
To determine the suitability of prostate organoids for ex vivo
genetic manipulation, we silenced Pten expression in PBCre
Rosa26LSL-ERG organoids by infection with lentivirus encoding
a shRNA targeting Pten. Puromycin selection was applied to
ensure that only infected organoids remained (Figure 3B). Seven
days postinfection, we observed an 80%–90% decrease in Pten
mRNA levels (Figures 3C and S3D), accompanied by increased
phosphorylation of AKT and ribosomal protein S6 (Figures 3D
and S3E), consistent with increased PI3K activation. Remark-
ably, the shPten-infected organoids displayed hyperplastic phe-
notypes (Figure 3E). Similarly, shPten-infected Rosa26 LSL-ERG
organoids generated hyperplastic prostate glandular tissue in
UGSM tissue recombination experiments, similar to that seen
in thePtenloxP/loxP/Rosa26LSL-ERG grafts, control shRNA-infected
organoids showed no signs of hyperplasia (Figure 3E). Similar to
earlier work in GEMM models showing that hyperactive PI3K
signaling in Pten null prostate tissue results in reduced Ar tran-
scriptional activity due to negative feedback on Her kinase sig-
naling(Carver et al., 2011), we observed reduced expression of
the Ar target genes Psca and Fkbp5 in organoids with Pten
knockdown (Figures 3C and S3D). Collectively, these results
show that in vitro prostate organoid phenotypes mimic in vivo
phenotypes and that retroviral gene expression or gene knock-
down in organoids can be used to identify and study genes
involved in prostate cancer.
Establishment of Human Prostate Organoids with Basal
and Luminal Cells
Based on our previous experience (Sato et al., 2011), we antic-
ipated that human prostate organoid cultures might require
additional growth factors. Fibroblast growth factor-10 (FGF10),
FGF2, and prostaglandin E2 (PGE2) have been shown to sup-
port proliferation of prostate cell lines and/or human colon
epithelium (Jung et al, 2011; Memarzadeh et al., 2007). There-
fore, we added these to the ‘‘mouse’’ medium (ENR+A83-
01+DHT). We also included nicotinamide and the p38 inhibitor
SB202190, which have been previously identified as being
essential for human small intestinal cultures (Sato et al., 2011).
This combination of growth factors enabled us to establishand propagate human prostate epithelial organoids from 40
independent normal prostate specimens from patients undergo-
ing radical prostatectomy. Human prostate organoids have
been passaged for >12 months with no obvious phenotypic
changes over time and with stable, normal karyotypes (Figures
S4A and S4B). To determine the genetic stability of our organoid
cultures at the nucleotide level, we performed whole-exome
sequencing on passage 2 and passage 7 organoids. To detect
genetic changes that developed during in vitro expansion, we
filtered single-nucleotide variants (SNVs) and small insertions
and deletions (indels) observed in the long-term culture for pres-
ence in the short-term culture (see Experimental Procedures).
Subsequently, candidate changes that emerged using this
approach were independently examined (Table S1). In addition,
we also checked for cases of loss of heterozygosity in the pas-
sage 7 cultures compared to passage 2 cultures. We did not
observe any genetic variants in the passage 7 culture that
were not present in the passage 2 culture, implying that the or-
ganoid cultures remain genetically stable over time.
Initially, we observed solid spherical structures with multiple
layers of epithelium, which progressed over 2–3 weeks to orga-
noids with easily visible lumens. Areas of single-layered as well
as double-layered epithelium were observed. The majority of
cells were positive for the luminal epithelial markers CK8 and
AR (Figures 4A–4C). Typically, cells expressed either the basal
marker CK5 or the luminal marker CK8. Cells positive for basal
markers p63 and CK5 were also present and were always
located in the outer layer of organoids (Figures 4A–4C). Similar
to mouse-derived prostate organoids, human organoids ex-
pressed prostate-specific genes such as PSA (Figures 4D–4E)
and NKX3.1 (Figurse 4B and 4E). Additionally, human organoids
retained intact AR signaling as measured by dose-dependent in-
duction of PSA mRNA by DHT (Figure 4D) and reduced expres-
sion of NKX3.1 and PSA upon DHT withdrawal (Figure 4E). In
addition, human organoids formed prostate glands in UGSM tis-
sue recombination assays when transplanted after 8 passages
(Figure 4F), as also seen with murine prostate organoids.
Having established conditions for human prostate organoid
cultures, we examined the relative requirement for each growth
factor in maintaining the cultures. EGF, FGF2, nicotinamide,
PGE2 and the TGF-b pathway inhibitor A83-01 were all essential
to sustain prolonged organoid growth (Figures S4C and S4D).
Removal of the p38 kinase inhibitor SB202190 did not lead to a
decrease in organoid formation capacity but did result in histo-
logic evidence of keratinization, perhaps due to increased stress
signaling. Although passaging was not affected by the removal
of FGF10, Noggin or R-spondin, the efficiency of organoid for-
mation upon initial plating was reduced. Moreover, removal of
any one of these factors, as well as of nicotinamide, resulted
in decreased AR expression levels. In particular, removal of
R-spondin or Noggin led to a virtual disappearance of AR
expression (Figures 4G and S4E). Withdrawal of EGF resulted
in a modest upregulation of AR mRNA and protein level together
with a potent increase in expression of the AR target gene PSA
(Figures S4F–S4H). These data are consistent with a negative
feedback loop involving EGF and AR signaling and/or an inhibi-
tory effect of high levels of EGF signaling on the generation or
survival of luminal cells.Cell 159, 163–175, September 25, 2014 ª2014 Elsevier Inc. 167
Figure 3. Genetically Engineered Mouse Prostate Cancer Models Are Recapitulated in Organoids
(A) Brightfield and H&E images of wild-type (WT) (I and II), PBCre PtenloxP/loxP (III and IV), PBCre RosaLSL-ERG (V and VI), and PBCre PtenloxP/loxP RosaLSL-ERG
(VII and VIII). In PtenloxP/loxP organoids the lumen is filled with hyperplastic cells. PtenloxP/loxP/Rosa26LSL-ERG organoids make fingerlike protrusions are made into
the Matrigel (arrowheads, dashed lines, inset VIII).
(B) Schematic overview of retroviral infection.
(C) Quantitative RT-PCR analysis of Pten, Fkbp5, and Psca expression in shPten- and shScr-control-infected PBCre Rosa26 LSL-ERG organoids. Upon Pten
knockdown, Ar target gene expression is diminished. Expression was normalized to Hprt. Results are shown as mean ± SD.
(D)Western blot analysis of PI3K pathway activation in shPten- and ShScr-control-infected PBCre Rosa26 LSL-ERG organoids. p-Akt and p-S6 levels are increased
upon Pten knockdown.
(E) Brightfield image of shPten-RFP shScr-RFP-infected PBCre Rosa26LSL-ERG organoids (I and II) and corresponding H&E staining of shPten/shScr organoid-
UGSM recombinations (III and IV) showing hyperplastic phenotype in organoids and in UGSM recombinations upon Pten knockdown.
Scale bars in (A), (B), and (E) represent 50 mm unless noted differently. See also Figure S3
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Human Prostatic Epithelium Harbors Both Luminal and
Basal Stem Cells
Existing human prostate culture methods favor outgrowth of
basal epithelial cells that, in UGSM tissue recombination assays,
can generate prostate tissue with luminal cells, providing evi-
dence for human prostate stem cells in the basal epithelium
(Garraway et al., 2010; Goldstein et al., 2008). However, experi-
mental evidence for the existence of a human luminal stem cell is
lacking. Our success in propagating human organoids with basal
and luminal cells provided a unique opportunity to address this
question.
As with our mouse studies, we separated basal and luminal
cells from human prostate tissue by FACS. Basal cells were iso-
lated on the basis of high CD49f expression, and luminal cells by
the cell surfacemarker CD26 (also called DPPIV) (Liu et al., 2004)
(Figure 5A). Staining of these two populations for CK5 and CK8
postisolation verified their basal and luminal cellular identities
(Figure S5A). Additionally, we stained for the luminal marker
NKX3.1 and found that essentially all CD26-sorted cells express
NKX3.1 (Figure S5B). Although CD26 and CD49f are also ex-
pressed on immune cells, we only found very low numbers
of contaminating hematopoietic cells as measured by the pan-
leukocyte marker CD45 (<0.1% in 10,000 cells, three indepen-
dent samples). We detected very little contamination of CK5+
basal cells (<0.2%, 18 ± 1.7 in 10,000 cells, three independent
samples) in the FACS-purified luminal population.
To determine their relative organoid-forming ability, we
seeded single basal or luminal cells at varying densities. Human
basal cells were highly efficient at establishing organoids, be it at
single-cell density (70%) or at high density (1,000 cells/10 ml)
(Figure 5B). Luminal cells also established organoids, albeit at
much lower efficiency (1%–2%), both at single cell and at high
density seeding. Of note, this could not be explained by con-
taminating basal cells, as these were present at a >10-fold lower
frequency (<0.2%), suggesting the presence of a rare luminal or-
ganoid-forming cell.
Within 7 days of plating, single basal cells formed solid spheres
that, within 2–3 weeks, contained lumens resembling organoids
grown from bulk tissue, when viewed by brightfield microscopy.
However, unlike bulk-derived organoids, IHC analysis revealed
that the majority of cells in basal-derived organoids expressed
CK5, with CK8 cells surrounding a sporadic array of lumens
within a single organoid (Figure 5C). AR expression was patchy,
but tended to be near lumens (Figure 5C, Figure S5C). In contrast
to basal-cell-derived organoids, those generated from luminal
cells immediately formed lumens and thus could be easily dis-
tinguished frombasal-derived organoids by brightfield. IHC anal-
ysis of luminal-derived organoids revealed a majority of cells
expressing CK8 and AR, consistent with a true luminal pheno-
type. Strikingly, CK5-positive, CK8-negative cells were also
observed (Figure 5C), indicating that human luminal cells can
generate basal cells. Consistent with their differing histology,
the luminal markers NKX3.1 and PSA were strongly expressed
in luminal organoids whereas the basal marker p63 was more
highly expressed in basal organoids (Figure 5D, 5E). Both orga-
noid types retained AR pathway signaling, as DHT withdrawal
led to a significant decrease in PSA expression levels (Figure 5E)
and a reduced nuclear localization of AR (Figure S5H).Both basal- and luminal-derived organoids could be passaged
for at least 4 months and maintained a stable karyotype (Fig-
ure S5D). A more detailed analysis of relative growth factor re-
quirements revealed few differences compared to bulk human
organoid cultures (Figures S5E and S5F), most notably that
luminal organoids were more dependent on R-spondin for serial
passaging. Expression analysis using RT-PCR of Lgr receptors
revealed that LGR4 is expressed in both types of human organo-
ids (Figure S5G). The relative dependence of luminal cells on
R-spondin/Lgr signaling is also suggested by the reported failure
of luminal differentiation by Lgr4/ prostate progenitor cells
(Luo et al., 2013). DHT drastically enhanced luminal organoid
formation but, as observed with mouse, was not absolutely
required for organoid maintenance (Figures S5E and S5F). The
p38 inhibitor was not required to prevent keratinization. As
seen with organoids derived from bulk tissue, we observed a
loss of nuclear AR staining as well as a decrease in AR protein
levels upon DHT withdrawal (Figure S5H). We also observed a
strong increase in PSA expression upon EGF withdrawal in
both luminal- and basal-cell-derived organoids (Figure S5I).
To formally demonstrate that single luminal cells can give rise
to organoids containing both lineages, we repeated these exper-
iments after plating single luminal cells. As observed in bulk, sin-
gle basal-cell-derived organoids proliferated much faster over
time than single luminal-cell-derived organoids. As observed in
bulk, luminal cells quickly formed lumens, whereas basal cells
first formed solid spheres (Figure 6A). IF staining of single cell-
derived organoids showed that both basal and luminal cells
generated organoids containing both lineages as demonstrated
by the presence of CK8+ luminal and CK5+ basal cells (Fig-
ure 6B), providing conclusive evidence for a human multiproge-
nitor prostate cell in the luminal compartment.
DISCUSSION
Leveraging our previous experience establishing organoid cul-
tures, we have devised a culture system that allows long-term
expansion of murine and human prostatic epithelium. The result-
ing organoids retain both basal and luminal epithelial layers and
preserve androgen-responsiveness in culture. Organoids differ
significantly from earlier descriptions of prostate spheres, which
consist primarily of CK5+ basal cells with luminal-like features in
response to DHT treatment, but lack NKX3.1+ cells or secretions
(Xin et al., 2007). In contrast, our culture conditions induce full
luminal differentiation. These conditions were developed using
growth factors originally optimized for intestinal epithelia, with
some modifications. We conducted studies to address the
requirement for each of these growth factors when removed
from the complete cocktail, but have not exhaustively examined
all possible perturbations.
Organoids proliferate at a much higher rate compared to
normal prostate. We assume that organoid culture conditions
mimic a regenerative response. In contrast to gastrointestinal
organoid cultures, R-spondin is not essential for maintenance
of prostate organoid cultures. However, organoid establish-
ment andgrowth is enhancedbyR-spondin. Importantly, expres-
sion of AR is strongly dependent on R-spondin. Taken together,
our data and previous studies suggest that R-spondin/LgrCell 159, 163–175, September 25, 2014 ª2014 Elsevier Inc. 169
Figure 4. Establishment of Human Prostate Organoid Cultures
(A) IHC analysis of passage 6 (12 week) human organoids in the presence of DHT (1 nM) and in castrate conditions. Brightfield image (I and II), H&E staining (III and
IV), p63 (V and VI), CK8 (VII and VIII), and AR (IX and X). Upon DHT addition nuclear localization of the AR is observed. Scale bars, 50 mm unless noted differently.
(B) RT-PCR analysis of prostate organoids show that both luminal and basal markers are expressed in the absence and presence of DHT (1 nM).
(C) IF staining of basal CK5 (green) and luminal CK8 (red) in organoids. Distinct luminal and basal cell populations are present in organoids.
(D) Quantitative RT-PCR analysis of PSA 24 hr after DHT stimulation (0–100 nM). Expression was normalized toGAPDH. Results are shown as mean ± SD (n = 3)
(E) Quantitative RT-PCR analysis of AR targets NKX3.1 and PSA in the presence of DHT (1 nM) and without DHT (castrate) (24 hr). Upon DHT addition, a strong
increase of PSA and NKX3.1 transcript is observed. Expression was normalized to GAPDH. Results are shown as mean ± SD (n = 3).
(legend continued on next page)
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signaling is important for luminal cell differentiation and luminal
cell maintenance.
Several other factors, like FGF10 and Noggin, favor differenti-
ation toward a luminal phenotype, by positively regulating AR
expression. It is plausible that, in vivo, the stroma supplies
most if not all of these factors. Work from others has demon-
strated that the Rho/ROCK kinase inhibitor Y-27632 allows
long-term culture of primary epithelial tissue cultures, including
prostate, in conjunction with stroma-derived feeder cells (Liu
et al., 2012). Possibly, the growth factor composition of our cul-
ture method mimics the factors secreted by the feeder cells in
this method. In contrast to our method, AR responsiveness is
not well defined in this system. Preliminary studies of Y-27632
in our system suggest a benefit in initiating single cell organoid
cultures, but not in propagation of established organoids.
The availability of a robust culture model that generates pros-
tate organoids containing both basal and luminal cells allowed us
to address the important question of whether basal or luminal
cells (or both) are required to generate a complete prostate orga-
noid. Prior efforts to explore the ‘‘prostate stem cell’’ question
have primarily relied on UGSM tissue recombination assays.
These experiments have shown that tissue-regenerating activity
primarily resides in basal cell populations (Goldstein et al., 2008).
However, murine lineage-tracing studies demonstrate that both
basal and luminal cells are self-renewing, including evidence that
luminal cells can give rise to basal cells (Choi et al., 2012; Wang
et al., 2013). Our culture method confirms that basal and luminal
cells can each generate a complete multilayer prostate organoid
and shows repopulating potential of human prostate luminal
cells which can generate both basal and luminal lineages.
Although these luminal progenitor cells occur at lower frequency
than their basal counterparts, they give rise to more normal ap-
pearing organoids and therefore could have greater physiologic
relevance. Their frequency (1% of all luminal cells) raises the
question of whether these CD26+ and NKX3.1+ luminal cells
may be the human equivalent of the murine castration-resistant
Nkx3.1+ cell (CARN) (Wang et al., 2009).
This culture method, compared to other experimental proce-
dures, uniquely allows for elucidation of the cellular identity of
this human luminal progenitor. In the absence of evidence of
neuroendocrine differentiation, we refer to these luminal and
basal cells as multipotent progenitors rather than stem cells.
Modifications to the culture conditions may reveal that these
cells may also have neuroendocrine cell repopulating potential.
In addition to their utility in defining prostate epithelial lineage
relationships, the organoid model has the potential to greatly
facilitate functional genetic studies, particularly in cancer geno-
mics. Several large-scale prostate cancer genome resequencing
studies have nowdefined a plethora of novel genomic alterations
in primary and metastatic cancer whose functions are currently
unknown (Barbieri et al., 2012; Grasso et al., 2012; Taylor
et al., 2010). Here, we have shown that murine prostate organo-(F) H&E stain of UGSM recombination 8 weeks after transplantation of 50,000 hu
cells. Scale bars, 100 mm.
(G) Quantitative RT-PCR of AR mRNA levels in the absence of growth factors. W
expression. Expression was normalized to GAPDH. Results are shown as mean
See also Figure S4.ids faithfully recapitulate in vivo phenotypes known from pros-
tate cancer GEMMs. Moreover, the organoids are easily manip-
ulated with inhibitors, retroviruses and CRISPR/Cas9 (Schwank
et al., 2013), offering a tool to study the impact of these manipu-
lations on growth, invasive behavior, and drug sensitivity. Orga-
noid culture may also represent a straightforward, cheap, and
robust alternative to xenografting.
There is considerable interest in whether these same culture
conditions can be used to generate organoids from human pros-
tate cancers. If successful, this technology could help address a
huge need in the prostate cancer biology field for a broad array of
human prostate cancer cell lines, which has been forced to rely
on the very few such cell lines that have been established to date.
In a companion paper, Gao et al. (2014, this issue) show that
this culture method does allow efficient and sustained growth
of human prostate cancer organoids isolated from men with
advanced disease that faithfully retain the genomic characteris-
tics of the originating human tissue sample. We have conducted
similar studies using primary human prostate cancer samples
but failed to establish renewable primary cancer organoid lines,
due to overgrowth by normal prostate epithelial cells present
within each tumor sample. The notion that cells harboring onco-
genic mutations grow slower than normal cells may be counter-
intuitive, yet we also observe this consistently for colorectal and
pancreas cancers. The observed increased rates of apoptosis in
cancer organoid cultures may reflect the high levels of genomic
instability. The absence of normal prostate cells in metastatic
samples may explain the high rate of success of our method in
that context. Efforts to overcome this complication by purifica-
tion of tumor cells from normal epithelium are ongoing. Taken
together, prostate organoid technology offers a platform for
mechanistic studies of prostate development, homeostasis,
and cancer.EXPERIMENTAL PROCEDURES
Isolation and Culture of Prostate Epithelial Cells
Murine prostates were divided into three lobe pairs; AP, DLP, and VP. Lobes
were enzymatically digested with collagenase type II (GIBCO) and sub-
sequently with TrypLE (GIBCO). Cells were seeded in growth factor reduced
Matrigel (Corning) and overlayed with medium containing the growth factors:
EGF 5-50 ng/ml (Peprotech), R-spondin1 conditionedmediumor 500 ng/ml re-
combinant R-spondin1 (Peprotech), Noggin conditionedmedium or 100 ng/ml
recombinant Noggin (Peprotech), and the TGF-b/Alk inhibitor A83-01 200 nM
(Tocris). Dihydrotestosterone (DHT) (Sigma) was added at 0.1–1 nM. Human
prostate samples were obtained from patients undergoing radical prostatec-
tomy according to guidelines from the UMCUtrecht. Prostate tissue was enzy-
matically digested with collagenase type II and subsequently with TrypLE.
Cells were seeded in growth factor reduced Matrigel and cultured in medium
containing growth factors as above, with the addition of 10 ng/ml FGF10 (Pe-
protech), 5 ng/ml FGF2 (Peprotech), 1 mM Prostaglandin E2 (Tocris), 10 mM
SB202190 (Sigma-Aldrich), 10 mM nicotinamide (Sigma-Aldrich), and DHT
0.1–1 nM. For detailed summary of culture medium composition see Extended
Experimental Procedures.man organoid cells derived. Inset; CK5 staining, confirming presence of basal
ithdrawal of Noggin, R-spondin, FGF10, and nicotinamide led to reduced AR
± SD.
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Figure 6. Single Human Basal and Luminal
Cells Give Rise to Organoids
(A) Brightfield images of organoids grown from
single CD26+ luminal and CD49f+ basal cells.
(B) IF stain of CK5 (green) and CK8 (red) showing
distinct basal and luminal cells in single luminal-
cell- and single basal-cell-derived organoids
(passage 4). Scale bars, 50 mm.FACS
Single cell suspensions of human cells were stained using CD49f-alexa 647
(1:200, GoH3, BD Biosciences) and CD26-FITC (1:200, M-A261, eBioscience).
Murine cells were stained using a CD49f-PE (1:200, GoH3, BD Biosciences)
and CD24-alexa 647 (1:200, 30-F1, eBioscience).
UGSM Essay
UGSM recombination essay was performed as described previously (Xin et al.,
2003). All mouse work was performed in accordance with national guidelines
and regulations of the Hubrecht institute (DEC committee) or Memorial Sloan
Kettering Cancer Center (RARC committee).
Genetic Analysis
DNA was isolated from early (P2) and late (P7) passage organoids. Whole-
exome sequencing and genetic analysis were done as described previously
(DePristo et al., 2011; Li and Durbin, 2009). Detailed discription is given in
Extended Experimental Procedures. The data for the whole-exome
sequencingwere deposited to the EMBLEuropeanNucleotide Archive, acces-
sion number: ERP006541.
Immunohistochemistry and Immunofluorescence
Organoids were processed and stained as described previously(Sato et al.,
2009). The following antibodies were used for staining on murine and human
prostate organoids AR (1:1,000, N-20, Santa Cruz), CK5 (1:2,000, AF-138, Co-
vance), CK8 (1:50, C-51, Santa Cruz), p63 (1:800, 4A4, Millipore). Stainings
were visualized with bright vision (Dako). For IF organoids were stained for
AR (1:200) Ck5 (1:500), Ck8 (1:50), p63 (1:500) using the antibodies described
above and NKX3.1 (rabbit, 1:100, kind gift of Michael Shen). Secondary anti-
bodies were conjugated with Alexa-Fluor (488, 568, 647). DNA was
stained with DAPI.Figure 5. Establishment of Human Prostate Organoid Cultures from Luminal and Basal Cells
(A) FACS plot of human prostate cells stained with CD26 (luminal) and CD49f (basal) markers.
(B) Organoid outgrowth from CD49f+ basal and CD26+ luminal cells at varying densities. Results are shown a
CD49f-derived organoids fuse, making counting of organoid number therefore unreliable. Results are shown
(C) Analysis of CD26-derived (luminal) and CD49f-derived (basal) organoids at passage 4. Brightfield picture (
(VII and VIII) p63 (IX and X) AR (XI and XII) IF stain of CK5 (green) and CK8 (red) showing distinct basal and lu
noted otherwise.
(D) Quantitative RT-PCR expression analysis of the luminal marker NKX3.1 and basal marker p63 in luminal a
normalized to GAPDH. Results are shown as mean ± SD.
(E) Quantitative RT-PCR of the AR target PSA in the presence of DHT (1 nM) and in castrate conditions (24 hr)
luminal- and basal-derived organoids after DHT treatment. Expression was normalized to GAPDH. Results a
See also Figure S5
Cell 159, 163–175, SeLentiviral Infections
Lentiviral infections were performed as described
previously (Koo et al., 2012) using pLKO.1-puro-
UbC-TagFP635 (Sigma) targeting Pten (CGACT
TAGACTTGACCTATAT) or control Scramble (CC
TAAGGTTAAGTCGCCCTCG).
Western Blot
Membranes were probed with antibodies directed
against AR (1:1,000, N-20, Santa Cruz), GAPDH
(1:2,000 Abcam) AKT (1:1,000 Cell Signaling
#9272), phosphorylated-AKT (Ser473) (1:1,000Cell Signaling #4060), and phosphorylated-S6 (Ser235/Ser236) (1:1,000, Cell
Signaling #2211). Signal was visualized with secondary HRP conjugated anti-
bodies and ECL.
ACCESSION NUMBERS
The EMBL European Nucleotide Archive accession number for the whole-
exome sequencing reported in this paper is ERP006541.
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